by Plus Therapeutics | Sep 4, 2024 | PBC
September is #ChildhoodCancerAwarenessMonth and we want to raise awareness for pediatric #braincancer resources 💛 These advocacy groups have a wealth of knowledge so please follow & share to #patients & #caregivers: (More can be found on our website:...
by Plus Therapeutics | Apr 29, 2024 | PBC
Following our EXCITING NEWS about our $3 Million award recommendation from the United States Department of Defense, we wanted to reshare our cancer guides for Pediatric High-Grade Glioma (https://www.respect-trials.com/patient-guide-hgg/) and Ependymoma...
by Plus Therapeutics | Apr 23, 2024 | PBC
Exciting news yesterday as $PSTV was able to share our recent $3 Million DoD Award for our ReSPECT-PBC Pediatric Brain Cancer Trial. Stock Region Article: https://bit.ly/4b4OBXG #Nasdaq #ClinicalResearch #ClinicalTrial #PediatricOncology...
by Plus Therapeutics | Apr 22, 2024 | PBC
BREAKING NEWS: Plus Therapeutics has been selected for funding by the Department of Defense (DoD) office of the Congressionally Directed Medical Research Programs (CDMRP). The award is expected to commence in Q3 2024 and will support the planned expansion of the...
by Plus Therapeutics | Feb 12, 2024 | PBC
We value patient education and want to provide some resources for Pediatric Brain Cancer caregivers 💛 Ependymoma Cancer Guide: https://www.respect-trials.com/patient-guide-ependymoma/ Pediatric High-Grade Glioma Cancer Guide:...
Recent Comments